Displaying One Session

Chairs
  • Dejan Juric (Boston, United States of America)

Welcome and introduction

Presenter
  • Dejan Juric (Boston, United States of America)

Introduction of the case

Presenter
  • Dejan Juric (Boston, United States of America)

Presentation and selection of a first-line therapy

Presenter
  • Fatima Cardoso (Lisbon, Portugal)

Panel discussion

Presenter
  • Dejan Juric (Boston, United States of America)
  • Fatima Cardoso (Lisbon, Portugal)
  • Hans-Christian Kolberg (Bottrop, Germany)

Spotlight presentation: Fulvestrant as combination partner in both first and second line

Presenter
  • Dejan Juric (Boston, United States of America)
  • Fatima Cardoso (Lisbon, Portugal)
  • Hans-Christian Kolberg (Bottrop, Germany)

Switching to a second-line treatment

Presenter
  • Hans-Christian Kolberg (Bottrop, Germany)

Panel discussion

Presenter
  • Dejan Juric (Boston, United States of America)
  • Fatima Cardoso (Lisbon, Portugal)
  • Hans-Christian Kolberg (Bottrop, Germany)

Putting the Case in Context

Presenter
  • Dejan Juric (Boston, United States of America)

Panel Discussion: COVID-19 and Patient Management

Presenter
  • Dejan Juric (Boston, United States of America)